Select Publications
Journal articles
2025, 'Randomized Controlled Trial of a Virtually Delivered Exercise and Stress Management Program to Improve Physical Performance of Hematopoietic Cell Transplant Survivors', Journal of Clinical Oncology, 43, pp. 949 - 959, http://dx.doi.org/10.1200/JCO.24.00333
,2025, 'Error-corrected ultradeep next-generation sequencing for detection of clonal haematopoiesis and haematological neoplasms - sensitivity, specificity and accuracy', Plos One, 20, pp. e0318300, http://dx.doi.org/10.1371/journal.pone.0318300
,2025, 'Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test', Journal of Clinical Oncology, http://dx.doi.org/10.1200/JCO-25-00331
,2024, 'Australian rheumatologists' perception of autologous haemopoietic stem cell transplantation for the treatment of systemic sclerosis: a cross-sectional survey', Internal Medicine Journal, 54, pp. 1478 - 1482, http://dx.doi.org/10.1111/imj.16422
,2024, 'Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?', Annals of Hematology, 103, pp. 1121 - 1129, http://dx.doi.org/10.1007/s00277-023-05191-9
,2024, 'James Crawford Biggs 1931-2023', Bone marrow transplantation, 59, pp. 291 - 292, http://dx.doi.org/10.1038/s41409-023-02170-6
,2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010
,2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', BLOOD, 142, http://dx.doi.org/10.1182/blood-2023-184319
,2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043
,2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709
,2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100, http://dx.doi.org/10.1177/23971983221145639
,2023, 'Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia', Science translational medicine, 15, pp. eabm1262 - eabm1262, http://dx.doi.org/10.1126/scitranslmed.abm1262
,2022, 'Potential benefits of a virtual, home-based combined exercise and mindfulness training program for HSC transplant survivors: a single-arm pilot study', BMC Sports Science Medicine and Rehabilitation, 14, http://dx.doi.org/10.1186/s13102-022-00554-7
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, 198, pp. 24 - 45, http://dx.doi.org/10.1111/bjh.18176
,2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209, http://dx.doi.org/10.1038/s41409-022-01696-5
,2022, 'Superassembled Hierarchical Asymmetric Magnetic Mesoporous Nanorobots Driven by Smart Confined Catalytic Degradation', Chemistry - A European Journal, 28, http://dx.doi.org/10.1002/chem.202200307
,2022, 'Meeting the COVID challenge: Optimizing vCD34+ in cryopreserved HPC samples for implementation of an external QA Program', Cytotherapy, 24, pp. 437 - 443, http://dx.doi.org/10.1016/j.jcyt.2021.10.009
,2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300
,2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510
,2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935
,2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128
,2021, 'Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic', Transplantation and Cellular Therapy, 27, pp. 1022 - 1022.e6, http://dx.doi.org/10.1016/j.jtct.2021.09.012
,2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106
,2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660
,2021, 'Standardization and Accreditation in Haemopoietic Stem Cell Transplantation - an Asia Pacific Perspective.', Blood Cell Ther, 4, pp. S14 - S19, http://dx.doi.org/10.31547/bct-2021-015
,2021, 'miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia', Leukemia, 35, pp. 1933 - 1948, http://dx.doi.org/10.1038/s41375-020-01095-z
,2021, 'Autologous Hematopoietic Stem Cell Transplantation for Behçet’s Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.638709
,2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
,2021, 'Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine', Science Advances, 7, pp. eabd1929, http://dx.doi.org/10.1126/sciadv.abd1929
,2021, 'Hematopoietic stem cell transplantation in autoimmune diseases: update from the EBMT Autoimmune Diseases Working Party with special reference to Poland', Acta Haematologica Polonica, 52, pp. 217 - 224, http://dx.doi.org/10.5603/AHP.2021.0043
,2021, '3101 – MIR-10A AS A THERAPEUTIC TARGET AND PREDICTIVE BIOMARKER FOR MDM2 INHIBITION IN ACUTE MYELOID LEUKEMIA', Experimental Hematology, 100, pp. S91 - S91, http://dx.doi.org/10.1016/j.exphem.2021.12.318
,2021, '3133 – DIRECT COMPARISON OF IMPROVED METHOD FOR HUMAN INDUCED PLURIPOTENT STEM CELL (IPSC) HAEMATOPOIETIC DIFFERENTIATION SHOWS ENHANCED EFFICIENCY AND SENSITIVITY AT REDUCED COST', Experimental Hematology, 100, pp. S107 - S107, http://dx.doi.org/10.1016/j.exphem.2021.12.350
,2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030
,2020, 'Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells', Stem Cell Reports, 15, pp. 735 - 748, http://dx.doi.org/10.1016/j.stemcr.2020.07.009
,2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005
,2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 55, pp. 857 - 866, http://dx.doi.org/10.1038/s41409-019-0710-2
,2020, 'Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)', Bone Marrow Transplantation, 55, pp. 283 - 306, http://dx.doi.org/10.1038/s41409-019-0684-0
,2019, 'Favorable Outcome of Lung Transplantation for Severe Pulmonary Graft Versus Host Disease: An Australian Multicenter Case Series', Transplantation, 103, pp. 2602 - 2607, http://dx.doi.org/10.1097/TP.0000000000002693
,2019, 'Country Report: The Report of Transplant Activity and Outcome During the First 12 Months at the First National Hematopoietic Stem Cell Transplant Center in Sri Lanka.', Blood Cell Ther, 2, pp. 50 - 53, http://dx.doi.org/10.31547/bct-2019-007
,2019, 'Role of hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a report of 2 unique cases.', Blood Cell Ther, 2, pp. 36 - 38, http://dx.doi.org/10.31547/bct-2019-001
,2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446
,2019, 'Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study', Lancet Haematology, 6, pp. e67 - e78, http://dx.doi.org/10.1016/S2352-3026(18)30217-5
,2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, 53, pp. 1478 - 1482, http://dx.doi.org/10.1038/s41409-018-0215-4
,2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, 40, pp. 533 - 539, http://dx.doi.org/10.1111/ijlh.12857
,2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410
,2018, 'Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. 169 - 174, http://dx.doi.org/10.1016/j.bbmt.2017.09.011
,2018, 'Dealing with the spiralling price of medicines: issues and solutions', Internal Medicine Journal, 48, pp. 16 - 24, http://dx.doi.org/10.1111/imj.13652
,2018, 'Working together: Establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka', Blood Advances, 2, pp. 46 - 49, http://dx.doi.org/10.1182/bloodadvances.2018GS110686
,2018, 'Activity and Capacity Profile of Transplant Physicians and Centres in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. S310 - S311, http://dx.doi.org/10.1016/j.bbmt.2017.12.319
,